findmyKOL

Directory

KOLs working with Adaptive Biotechnologies

36 key opinion leaders with clinical trial sponsorships or reported industry payments from Adaptive Biotechnologies. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.

The 24 most cited

Paul Richardson, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyNortheast · MA
2,062
publications
172
h-index
18
trials
View profile →

Gareth Morgan, MD

NYU Langone Health

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyNortheast · NY
1,922
publications
126
h-index
4
trials
View profile →

Stephan Grupp, MD

Children's Hospital of Philadelphia

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · PA
804
publications
105
h-index
13
trials
View profile →

William Wierda, MD, PhD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologySouth Central · TX
1,533
publications
122
h-index
19
trials
View profile →

Elias Jabbour, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologySouth Central · TX
2,365
publications
115
h-index
38
trials
View profile →

Robert Orlowski, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySouth Central · TX
1,164
publications
102
h-index
10
trials
View profile →

Rafael Fonseca, MD

Mayo Clinic

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematologyWest · AZ
894
publications
121
h-index
3
trials
View profile →

Bruce Cheson, MD

The Center for Cancer and Blood Disorders

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaHematologyNortheast · MD
655
publications
89
h-index
5
trials
View profile →

David Siegel, MD

John Theurer Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · NJ
699
publications
83
h-index
9
trials
View profile →

Daniel Deangelo, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
933
publications
93
h-index
10
trials
View profile →

Tapan Kadia, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLeukemiaInternal MedicineSouth Central · TX
1,816
publications
91
h-index
30
trials
View profile →

Frederick Locke, MD

H. Lee Moffitt Cancer Center and Research Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySoutheast · FL
863
publications
62
h-index
8
trials
View profile →

Richard Furman, MD

Weill Cornell Medicine

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematologyNortheast · NY
506
publications
76
h-index
4
trials
View profile →

Richard Maziarz, MD

Oregon Health & Science University

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyWest · OR
720
publications
86
h-index
9
trials
View profile →

Wendy Stock, MD

University of Chicago Medicine

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyMidwest · IL
894
publications
79
h-index
19
trials
View profile →

Alessandra Ferrajoli, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaMedical OncologySouth Central · TX
934
publications
93
h-index
19
trials
View profile →

Parameswaran Hari, MD

Obsidian Therapeutics

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyMidwest · WI
917
publications
79
h-index
6
trials
View profile →

Paul Barr, MD

University of Rochester Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyNortheast · NY
837
publications
55
h-index
25
trials
View profile →

Andrzej Jakubowiak, MD, PhD

University of Chicago

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyMidwest · IL
477
publications
68
h-index
11
trials
View profile →

Michael Verneris, MD

University of Colorado School of Medicine

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileGenitourinaryHematology / OncologyWest · CO
497
publications
67
h-index
6
trials
View profile →

Ivan Borrello, MD

Tampa General Hospital Cancer Institute

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologySoutheast · FL
282
publications
60
h-index
7
trials
View profile →

Matthew Davids, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
653
publications
61
h-index
9
trials
View profile →

Suzanne Lentzsch, MD

Columbia University Irving Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · NY
512
publications
59
h-index
6
trials
View profile →

Nicholas Short, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLeukemiaInternal MedicineSouth Central · TX
1,096
publications
66
h-index
15
trials
View profile →

Filter, sort, and export all 36 working with Adaptive Biotechnologies in the directory